Characterization of oral disintegrating film containing donepezil for Alzheimer disease

AAPS PharmSciTech

Volumn 13, Issue 1, 2012, Pages 134-142

  Liew, Kai Bin ^a   Tan, Yvonne Tze Fung ^a   Peh, Kok Khiang ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Alzheimer disease; Donepezil HCl; Oral disintegrating film; Palatability

Indexed keywords

ASPARTAME; DISINTEGRATING AGENT; DISINTEGRATING FILM; DONEPEZIL; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; MACROGOL; SACCHARIN; STARCH; SUCRALOSE; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ARTICLE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MALE; NORMAL HUMAN; PALATABILITY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TASTE; TENSILE STRENGTH; THICKNESS;

ADMINISTRATION, ORAL; ALZHEIMER DISEASE; CHEMISTRY, PHARMACEUTICAL; DOUBLE-BLIND METHOD; DRUG CARRIERS; FEMALE; HUMANS; INDANS; MALE; PIPERIDINES; SOLUBILITY; SWEETENING AGENTS; TASTE; TENSILE STRENGTH; YOUNG ADULT;

EID: 84861092419     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-011-9729-4     Document Type: Article

References (37)

1. Joseph TD, Robert LT, Gary CY, Gary RM, Barbara GW, Michael LP. Pharmacotherapy: a pathophysiologic approach. 6th ed. New York: McGraw Hill; 2005. p. 2162-87.
2. Martin RF. Effective pharmacologic management of Alzheimer disease. AJM. 2007;120:388-97.
3. Hanawa T. Development of a new and kindly oral dosage form for elderly. JPST. 1997;13:251-8.
4. Yamamoto Y, Fujii M, Watanabe K, Tsukamoto M, Shibata Y, Kondoh M, et al. Effect of powder characteristics on oral tablet disintegration. Int J Pharm. 2009;365:116-20.
5. Sunada H, Bi YX. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol. 2002;122:188-98. (Pubitemid 34041549)
6. Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier Jp, Piccerelle Ph. Determination of the in-vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm. 2005;292:29-41. (Pubitemid 40255786)
7. Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139:94-107.
8. Goel H, Rai P, Rana V, Tiwary AK. Orally disintegrating systems: innovations in formulation and technology. Recent Patents on Drug Delivery and Formulation. 2008;2:258.
9. Mishra R, Amin A. Formulation development of taste-masked rapidly dissolving films of cetirizine hydrochloride. Pharmtech. 2009;33(2):48-56.
10. Pillai R, Karatgi P. Orally disintegrating tablets: the path to improved patient compliance and enhanced life cycle management. Pharmtech Europe. 2009;21(5):37-41.
11. Shimoda H, Taniguchi K, Nishimura M, Matsuura K, Tsukioka T, Yamashita H, et al. Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy. Eur J Pharm Sci. 2009;73:361-5.
12. Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Sugiyama T, et al. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. Int J Pharm. 2009;368:98-102.
13. Chambin O, Champion D, Debray C, Rochat-Gonthier MH, Le Meste M, Pourcelot Y. Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage. J Control Release. 2004;95:101-8. (Pubitemid 38167684)
14. Yan YD, Jong SW, Kang JH, Yong CS, Choi HG. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets. Biol Pharm Bull. 2010;33 (8):1364-70.
15. Borsadia SB, O'Halloran D, Osborne JL. Quick-dissolving films - a novel approach to drug delivery. Drug development and delivery. 2003;3(3). Available online at http://www.drugdeliverytech.com/ME2/dirmod.asp?sid=&nm=&type= Publishing&mod=Publications%3A%3AArticle&mid= 8F3A7027421841978F18BE895F87F791&tier=4&id= 1462E9E570724362AF256AB9CEC63126.
16. Koh N, Sakamoto S, Chino F. Improvement in medication compliance and glycemic control with voglibose oral disintegrating tablet. Tohoku J Exp Med. 2008;216(3):249-57.
17. Bruce JK, Angela LH, Liu H, Sara KW. Olanzapine orally disintegrating tablet in the treatment of acutely ill non-compliant patients with schizophrenia. IJNP. 2003;6:97-102. (Pubitemid 36850960)
18. Raviraj P, Pradeep K. Orally disintegrating tablets: the path to improve patient compliance and enhanced life cycle management. Pharmtech Europe. 2009;21:5.
19. Emilio MC, Vincente GG, Albert NS, Jose PF, Joan HN, Jordi GC, et al. A study on the subjective compliance and acceptance of oral lanzoprazole in traumatology. The ECOFT-TR Study. Clin Rheumatol. 2009;5(2):49-54.
20. Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note. AAPS PharmSciTech. 2007;8(1):13.
21. Mishra R, Amin A. Manufacturing techniques of orally dissolving films. J Pharm Sci. 2011;35(1):70-3.
22. Pappa H, Farrú R, Vilanova PO, Palacios M, Pizzorno MT. A new HPLC method to determine donepezil hydrochloride in tablets. J Pharmaceut Biomed. 2002;27:177-82. (Pubitemid 33001394)
23. Japanese Pharmacopoeia 15. General tests, processes and apparatus. Tokyo, Japan: The Society of Japanese Pharmacopoeia. p. 107.
24. Cilurzo F, Cupone IE, Minghetti P, Selmin F, Montanari L. Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm. 2008;70(3):895-900.
25. Kuno Y, Kojima M, Andoand S, Nakagami H. Effect of preparation method on properties of orally disintegrating tablets made by phase transition. Int J Pharm. 2008;355(1-2):87-92.
26. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009. p. 702.
27. Doe J. 2010 Sucralose - Technological Justification. www.food.gov.uk/ multimedia/pdfs/sucraconsult2.pdf. Accessed26 Oct 2010.
28. Rowe R, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009. p. 48.
29. Bayarri S, Izquierdo L, Costell E. Sweetening power of aspartame in hydrocolloids gels: influence of texture. Food Hydrocolloids. 2007;21:1265-74. (Pubitemid 46719560)
30. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009.
31. Riera CE, Vogel H, Simon SA, Coutre Jl. Artificial sweeteners and salts producing a metallic taste sensation activate TRPV1 receptors. Am J Physiol. 2007;293:626-34.
32. Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. A new formulation for orally disintegrating tablets using a suspension spray-coating method. Int J Pharm. 2009;382(1-2):80-7.
33. Chandrasekhar R, Hassan Z, AlHusban F, Smith AM, Mohammed AR. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets. Eur J Pharm Biopharm. 2009;72:119-29.
34. Kearney P, Rathbone MJ, Hadgraft R. The Zydis oral fast-dissolving dosage form. Modified-Release Drug Delivery Technology. 2002;2:191-201.
35. Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle Ph. The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J Pharm. 2004;278:423-33. (Pubitemid 38759514)
36. Park TJ, Ko DH, Kim YJ, Kim YG. Polymorphic characterization of pharmaceutical solids, donepezil hydrochloride, by C CP/MAS solid-state nuclear magnetic resonance spectroscopy. B Kor Chem Soc. 2009;30(9):2007-10.
37. Krishna R, Moses JB, Anil K, Chandrashekar, Vijayavitthal T, Eswaraiah S, et al. Identification and characterization of potential impurities of donepezil. J Pharmaceut Biomed. 2004;35 (5):1047-58. (Pubitemid 39140272)